Chiral
nanomaterials have drawn extensive attention on account
of numerous application prospects in optoelectronics, asymmetric catalysis,
chiral recognition, and three-dimensional (3D) display. Thereinto,
chiral perovskite has been a hotspot due to brilliant optoelectronic
properties, but some problems limit the development, including low
quantum yield, low chiral intensity, and the lack of facile regulation.
To overcome these issues, an effective ligand exchange strategy, i.e. the interface modification has been proposed for chiral
perovskite nanocrystals (PNCs). With the surface modification of CsPbBr3 PNCs with chiral organic ammonium in methyl acetate in the
typical purification process, excellent circular dichroism (CD) signals
were obtained and defects were eliminated, leading to an increase
in the photoluminescence quantum yield (PLQY) from 50% to nearly 100%.
The CD signal can be regulated through a ligand exchange strategy
in the longitudinal dimension, the chiral intensity, and the transverse
dimension, the wavelength range. Here, the proper addition of R-α-PEAI
into the R-α-PEABr-capped CsPbBr3 PNCs can produce
a superstrong CD signal with the highest anisotropy factor (g-factor) of 0.0026 in the visible region among reported
chiral colloidal PNCs. Simultaneously, the luminescence emission can
be tuned from the green to red region with boosted PLQY through the
approach. The density functional theory (DFT) calculation result supports
that chirality comes from the hybridization between the energy level
of a perovskite structure and that of chiral organic molecules. These
properties can be used in the structural engineering of high-performance
chiral optical materials, spin-polarized light-emitting devices, and
polarized optoelectronic devices.
Coupling
heterojunction is an effective and feasible approach to
suppressing the electron–hole recombination of a photocatalyst.
However, the heterojunction performance is limited by poor interface
contact between two semiconductors. Therefore, an in situ partial
conversion procedure was proposed to fabricate the flower-spherical
BiOI/Bi5O7I (BBOI) heterojunction using bacitracin
as a template. The introduction of bacitracin can regulate the assembly
of nanosheets into a flower-spherical structure, which caused the
BBOI photocatalysts to have larger specific surface areas than BiOI
or Bi5O7I. In particular, the dosage of bacitracin
can control the thermal conversion of BiOI to Bi5O7I. The in situ partial conversion of BiOI caused the formation
of an intimate S-scheme heterojunction interface between BiOI and
Bi5O7I, which efficiently inhibited the combination
of photogenerated carriers. Upon visible-light irradiation, BBOI-3
exhibited the highest catalytic ability for the simultaneous reduction
of Cr(VI) (100%) and oxidative degradation of tetracycline hydrochloride (TH) (80.0%). This
work provides an opinion to construct the high-performance heterojunction
photocatalysts to environmental remediation.
The novel Z-scheme flower-like Bi5O7I/Bi4Ti3O12 composites were prepared via in-situ grown under hydrothermal-calcination method, which were exhibited outstanding photocatalytic performance for selective oxidation of benzylic alcohols.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.